Apart from the Revlimid loss, generic price competition in the US, and the addition of new medical representatives in the ...
Hyderabad continues to emerge as one of India’s most dynamic hubs for pharmaceuticals, infrastructure, real estate, and ...
The appellate tribunal upheld dismissal of a belated company appeal, holding that limitation ran from the date the appellant admitted knowledge of the transfer. Time spent in a prior civil suit could ...
Get the latest Torrent Pharmaceuticals share price today on NSE & BSE. Explore Torrent Pharmaceuticals stock analysis, financial performance, market capitalization, dividend history, and future ...
The shares of Cipla dropped nearly 2 percent to its day's high on January 13 after the US FDA granted its final approval to ...
According to Nuvama, the increased competitive intensity following this approval is negative for Cipla, as it raises the risk ...
Khandelwal Laboratories Private Limited has made a slump sale of their non-oncology prescription formulation business, ...
Explore defensive investment strategies in healthcare and pharma sectors as opportunities arise amidst market volatility and ...
Hyderabad: CuraTeQ Biologics Private Limited, a wholly owned subsidiary of Aurobindo Pharma Limited, has received a Notice of ...
Aurobindo Pharma said its subsidiary CuraTeQ Biologics has received a Notice of Compliance from Health Canada for its ...
Get Dyrupeg biosimilar News on Telangana Today, Dyrupeg biosimilar latest news, Dyrupeg biosimilar news, | Telangana Today ...
ET Now on MSN
Aurobindo Pharma’s arm CuraTeQ Biologics receives Health Canada NOC for cancer drug biosimilar Dyrupeg
Aurobindo Pharma said its subsidiary CuraTeQ Biologics has received Health Canada’s compliance notice for its biosimilar ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results